Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Tokenizing Data to Improve Individual Health with Datavant

We have now entered a universe of “determinants of health” ranging from medical debt to housing to medication access to transportation…literally all things impact health that happen outside a doctor’s office. So is healthcare taking this into account? How are we helping those with substance abuse, rare cancers and unmanageable chronic conditions? On today’s episode…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

We have now entered a universe of “determinants of health” ranging from medical debt to housing to medication access to transportation…literally all things impact health that happen outside a doctor’s office.

So is healthcare taking this into account? How are we helping those with substance abuse, rare cancers and unmanageable chronic conditions?

On today’s episode of Healthcare Rethink, host Brian Urban, sits down with Claire Manneh, Head of Provider Research at Datavant, to talk about how the intuitive approach of tokenizing data is transforming how the healthcare ecosystem is reaching patients and improving lives!

Tune in to learn more about Claire’s public health background and her path to Datavant on this energizing episode!

The two discuss:

  1. What tokenization means and what it can do in healthcare and beyond
  2. How Claire’s work impacts health equity, health improvement
  3. Claire’s hopes for enabling lasting positive impact across the eco-system relative to data tokenization

Claire Manneh is the Head of Provider Research at Datavant. She graduated from the University of California, Berkeley and obtained a Bachelor’s Degree in Political Science and Government; Public Health Degree, Political Science, and Government.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Healthcare digital transformation stalls when teams stay disconnected

Healthcare digital transformation stalls when teams stay disconnected

Despite over 70% of healthcare executives prioritizing digital transformation, fragmented communication and information silos are hindering progress. Effective teamwork and integration are critical for achieving these goals. Bridging these gaps could enhance results in the healthcare industry's digital initiatives.

  • 01Over 70% of healthcare executives prioritize digital transformation.
  • 02Fragmented communication and information silos limit progress.
  • 03Effective integration is crucial for successful digital initiatives.

Jul 15, 2026

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512